Q'Apel Medical, a California-based private medical device company focused on neurovascular interventions, announced on Monday that it has named Jodie Fam as its new chief executive officer.
Fam succeeds R King Nelson, who retires after heading the firm for last five years and is to continue to work on the company's board of directors.
Fam has more than two decades of experience in the medical device industry. She has served in executive leadership positions at multiple medical device companies including public and several venture-backed start-ups. She has worked as Q'Apel's chief marketing officer and general manager for the company's international business. She has also worked as the CEO of AblaCare (now May Health) and in senior management positions at Route 92 Medical, Medina Medical (acquired by Medtronic), CardioKinetix and Concentric Medical (acquired by Stryker). She has served in senior clinical, sales and marketing positions with Guidant Corporation, Johnson & Johnson and Mallinckrodt Medical.
Johnson & Johnson agrees acquisition of V-Wave
Nightingale Health gains UKCA certification and expands with new laboratory
Talphera enrols first subject in NEPHRO CRRT study
China Pharma Holdings anticipates launch of Dry Eye Disease Therapeutic Device in early 2025
SOPHiA DDM Platform achieves IVDR certification, enhancing diagnostic precision
Medtronic reports FDA approval of Simplera CGM; partners with Abbott
OncoBeta expands Rhenium-SCT (Skin Cancer Therapy) treatment services in Italy
Labcorp's PGDx elio plasma focus Dx receives US FDA De Novo marketing authorisation
Verici Dx announces completion of Thermo Fisher Scientific licensing agreement
Polarean Imaging enters into trade-in agreement with University of Kansas Medical Center